Green Thumb Industries (GTBIF) Shares Outstanding (Weighted Average) (2018 - 2026)
Green Thumb Industries (GTBIF) reported Shares Outstanding (Weighted Average) of $230.6 million for Q1 2026, down 2.34% on a YoY basis from $236.1 million in Q1 2025, and down 1.4% quarter-over-quarter from $233.9 million in Q4 2025.
Green Thumb Industries (GTBIF) Shares Outstanding (Weighted Average) (2018 - 2026) Analysis & Trends
Green Thumb Industries has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $230.6 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 2.34% year-over-year to $230.6 million; the trailing twelve-month figure through Mar 2026 stood at $230.6 million (down 2.34% YoY), and the FY2025 full-year result was $233.9 million, down 1.26% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $230.6 million, down from $233.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $239.5 million in Q3 2023, with the low at $230.6 million in Q1 2026.
- Historically, Shares Outstanding (Weighted Average) has averaged $236.1 million across 5 years, with a median of $236.8 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) increased 9.08% — and 2026, when it decreased 2.34%.
- Green Thumb Industries' Shares Outstanding (Weighted Average) stood at $236.7 million in 2022, then rose by 0.51% to $237.9 million in 2023, then decreased by 0.45% to $236.8 million in 2024, then fell by 1.26% to $233.9 million in 2025, then slipped by 1.4% to $230.6 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $230.6 million (Q1 2026), $233.9 million (Q4 2025), and $231.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 230.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.60 Mn |
| Dec 31, 2025 | 233.87 Mn |
| Sep 30, 2025 | 231.65 Mn |
| Jun 30, 2025 | 235.84 Mn |
| Mar 31, 2025 | 236.12 Mn |
| Dec 31, 2024 | 236.85 Mn |
| Sep 30, 2024 | 236.30 Mn |
| Jun 30, 2024 | 237.42 Mn |
| Mar 31, 2024 | 236.76 Mn |
| Dec 31, 2023 | 237.93 Mn |
| Sep 30, 2023 | 239.46 Mn |
| Jun 30, 2023 | 238.00 Mn |
| Mar 31, 2023 | 237.40 Mn |
| Dec 31, 2022 | 236.71 Mn |
| Sep 30, 2022 | 237.00 Mn |
| Jun 30, 2022 | 236.78 Mn |
| Mar 31, 2022 | 235.84 Mn |
| Dec 31, 2021 | 223.19 Mn |
| Sep 30, 2021 | 226.53 Mn |
| Jun 30, 2021 | 220.32 Mn |